Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)

被引：1
|
作者：
Yuichi Terawaki
Chikayo Iwaya
Takashi Nomiyama
Dai Shimono
Tsuyoshi Horikawa
Yuki Fujimura-Tanaka
Toru Shigeoka
Nobuya Hamanoue
Ryoko Motonaga
Makito Tanabe
Toshihiko Yanase
Daiji Kawanami
机构：
[1] Fukuoka University,Department of Endocrinology and Diabetes Mellitus, School of Medicine
[2] Futata Tetsuhiro Clinic,undefined
[3] Muta Hospital,undefined
[4] Research Institute for Islet Biology,undefined
[5] Fukuoka University,undefined
来源：
Diabetology International | 2020年 / 11卷
关键词：
Dipeptidyl peptidase-4 inhibitor; Insulin secretagogue; Glucose oscillation; Hypoglycemia; Atherosclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：274 / 282
页数：8
相关论文
共 50 条
  • [41] The Efficacy, Safety, and Cost Effectiveness Evaluation of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes
    Feng, Yufei
    Li, Ting
    Xu, Lei
    Sun, Xuelin
    Hu, Xin
    DIABETES, 2017, 66 : A635 - A635
  • [42] EFFECT OF THE DIPEPTIDYL PEPTIDASE-4 INHIBITOR SITAGLIPTIN IN OLDER ADULTS WITH TYPE 2 DIABETES MELLITUS
    Stafford, Sara
    Elahi, Dariush
    Meneilly, Graydon S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (06) : 1148 - 1149
  • [43] Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Esaki, Hiroki
    Tachi, Tomoya
    Goto, Chitoshi
    Sugita, Ikuto
    Kanematsu, Yuta
    Yoshida, Aki
    Saito, Kosuke
    Noguchi, Yoshihiro
    Ohno, Yuki
    Aoyama, Satoshi
    Yasuda, Masahiro
    Mizui, Takashi
    Yamamura, Masumi
    Teramachi, Hitomi
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [44] Treatment with metformin and a dipeptidyl peptidase-4 inhibitor elevates apelin levels in patients with type 2 diabetes mellitus
    Fan, Yujuan
    Zhang, Yu
    Li, Xuesong
    Zheng, Hui
    Song, Yuping
    Zhang, Ning
    Shen, Chunfang
    Fan, Xiaofang
    Ren, Fengdong
    Shen, Jiayi
    Ren, Guoguang
    Yang, Jialin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 4679 - 4683
  • [45] Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
    Choi, Yeo Jin
    Kim, Dae Jung
    Shin, Sooyoung
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7427 - 7438
  • [46] Twelve-week efficacy and tolerability of sitagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor, in Japanese patients with type 2 diabetes
    Nonaka, K.
    Kakikawa, T.
    Sato, A.
    Okuyama, K.
    Fujimoto, G.
    Hayashi, N.
    Suzuki, H.
    Hirayama, Y.
    Stein, P. P.
    DIABETOLOGIA, 2006, 49 : 25 - 26
  • [47] Combination Therapy with a Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Metformin Markedly Improves HbA(1c) Levels in Japanese Patients with Type 2 Diabetes Mellitus
    Hirao, Koichi
    Maeda, Hajime
    Shirabe, Shin-ichiro
    Yamamoto, Ritsuko
    Hirao, Tetsuyuki
    Hirao, Setsuko
    Yamauchi, Mikio
    Arai, Keiko
    JAPANESE CLINICAL MEDICINE, 2012, 3 : 1 - 7
  • [48] Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis
    Dutta, Deep
    Agarwal, Anshita
    Maisnam, Indira
    Singla, Rajiv
    Khandelwal, Deepak
    Sharma, Meha
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (02) : 374 - 387
  • [49] Dipeptidyl peptidase-4 inhibitor cardiovascular safety in patients with type 2 diabetes, with cardiovascular and renal disease: a retrospective cohort study
    Baksh, Sheriza
    Wen, Jiajun
    Mansour, Omar
    Chang, Hsien-Yen
    McAdams-DeMarco, Mara
    Segal, Jodi B.
    Ehrhardt, Stephan
    Alexander, G. Caleb
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [50] Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes: Meta-Analysis
    Park, Haesuk
    Park, Chanhyun
    Kim, Yoona
    Rascati, Karen L.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (11) : 1453 - 1469
12345